Skip to main content

Table 2 Association between diuretic use and hospital mortality using an extended model approach

From: Early diuretic use and mortality in critically ill patients with vasopressor support: a propensity score-matching analysis

  Odds ratio of diuretic use 95% confidence interval P
Model 1 0.56 (0.47–0.67) < 0.001
Model 2 0.62 (0.51–0.74) < 0.001
Model 3 0.58 (0.48–0.71) < 0.001
Model 4 0.69 (0.55–0.81) < 0.001
Model 5 0.75 (0.62–0.91) 0.004
Model 5 0.69 (0.57–0.84) < 0.001
  1. Adjusted covariates: Model 1 = diuretic use. Model 2 = Model 1 + (comorbidities including intracranial hemorrhage, hypertension, acute kidney injury, coronary disease and diabetes). Model 3 = Model 2 + (gender, age, biochemical indices including white blood cell count and SOFA score on ICU admission). Model 4 = Model 3 + (fluid balance within 48 h after intensive care unit admission). Model 5 = Model 4 + (proportion of patients receiving vasopressors including norepinephrine, epinephrine, dopamine, and dobutamine). Model 6 = Model 4 + (dose of vasopressors including norepinephrine, epinephrine, dopamine, and dobutamine)
  2. Note: The mean variance inflation factor was 2.58 and 2.42 and the p value of the goodness of fit was 0.99 and 0.99 for Model 5 and Model 6, respectively
\